Primary Site >> Biliary tract Cancer

Gene >> STAT3

  • 2005
  • 2009
  • 2010
  • 2011
  • 2012
  • 2013
  • 2014
  • 2015
  • 2016
  • 2017
  • 2018
Ref: Interleukin 6 upregulates myeloid cell leukemia-1 expression through a STAT3 pathway in cholangiocarcinoma cells.
PMID: 16317687
Ref: Sorafenib inhibits signal transducer and activator of transcription-3 signaling in cholangiocarcinoma cells by activating the phosphatase shatterproof 2.
PMID: 19821497
Ref: Treatment of biliary tract cancer with NVP-AEW541: mechanisms of action and resistance.
PMID: 20066734
Ref: Significance of alternatively activated macrophages in patients with intrahepatic cholangiocarcinoma.
PMID: 20545696
Ref: Potent in vitro and in vivo antitumor activity of sorafenib against human intrahepatic cholangiocarcinoma cells.
PMID: 21331764
Ref: Hepatitis B virus X (HBx) induces tumorigenicity of hepatic progenitor cells in 3,5-diethoxycarbonyl-1,4-dihydrocollidine-treated HBx transgenic mice.
PMID: 21932402
Ref: Rapamycin inhibits both motility through down-regulation of p-STAT3 (S727) by disrupting the mTORC2 assembly and peritoneal dissemination in sarcomatoid cholangiocarcinoma.
PMID: 22875246
Ref: Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes.
PMID: 23295441
Ref: Intrahepatic cholangiocarcinoma: pathogenesis and rationale for molecular therapies.
PMID: 23318457
Ref: [Molecular mechanism of gamma-aminobutyric acid inhibitory on the growth of cholangiocarcinoma QBC939 cell line].
PMID: 23859331
Ref: Gankyrin promotes tumor growth and metastasis through activation of IL-6/STAT3 signaling in human cholangiocarcinoma.
PMID: 24037855
Ref: Quercetin and EGCG exhibit chemopreventive effects in cholangiocarcinoma cells via suppression of JAK/STAT signaling pathway.
PMID: 24038588
Ref: Luteolin arrests cell cycling, induces apoptosis and inhibits the JAK/STAT3 pathway in human cholangiocarcinoma cells.
PMID: 24998588
Ref: Differentiation therapy: sesamin as an effective agent in targeting cancer stem-like side population cells of human gallbladder carcinoma.
PMID: 25038821
Ref: STATs profiling reveals predominantly-activated STAT3 in cholangiocarcinoma genesis and progression.
PMID: 25044480
Ref: miR-17-92 cluster promotes cholangiocarcinoma growth: evidence for PTEN as downstream target and IL-6/Stat3 as upstream activator.
PMID: 25239565
Ref: FTY720 inhibits proliferation and epithelial-mesenchymal transition in cholangiocarcinoma by inactivating STAT3 signaling.
PMID: 25344679
Ref: Enhanced expression of suppresser of cytokine signaling 3 inhibits the IL-6-induced epithelial-to-mesenchymal transition and cholangiocarcinoma cell metastasis.
PMID: 25744243
Ref: Expression and activation of EGFR and STAT3 during the multistage carcinogenesis of intrahepatic cholangiocarcinoma induced by 3'-methyl-4 dimethylaminoazobenzene in rats.
PMID: 26028817
Ref: Comparative study of antitumor effects of bromelain and papain in human cholangiocarcinoma cell lines.
PMID: 26935541
Ref: Anoikis-resistant cholangiocarcinoma cells display aggressive characteristics and increase STAT3 activation.
PMID: 27107220
Ref: FXR agonists enhance the sensitivity of biliary tract cancer cells to cisplatin via SHP dependent inhibition of Bcl-xL expression.
PMID: 27127878
Ref: Leptin promotes proliferation and metastasis of human gallbladder cancer through OB-Rb leptin receptor.
PMID: 27211817
Ref: FAP Promotes Immunosuppression by Cancer-Associated Fibroblasts in the Tumor Microenvironment via STAT3-CCL2 Signaling.
PMID: 27216177
Ref: STAT3 overexpression promotes metastasis in intrahepatic cholangiocarcinoma and correlates negatively with surgical outcome.
PMID: 28032598
Ref: Resistance Mechanism against Trastuzumab in HER2-Positive Cancer Cells and Its Negation by Src Inhibition.
PMID: 28223426
Ref: Signaling pathways as therapeutic targets in biliary tract cancer.
PMID: 28282502
Ref: JAK2 tyrosine kinase inhibitor AG490 suppresses cell growth and invasion of gallbladder cancer cells via inhibition of JAK2/STAT3 signaling.
PMID: 28337870
Ref: Cryptotanshinone induces cell cycle arrest and apoptosis through the JAK2/STAT3 and PI3K/Akt/NFkappaB pathways in cholangiocarcinoma cells.
PMID: 28670110
Ref: Molecular targets for the therapy of cancer associated with metabolic syndrome (transcription and growth factors).
PMID: 29115033
Ref: Blocking of the EGFR-STAT3 signaling pathway through afatinib treatment inhibited the intrahepatic cholangiocarcinoma.
PMID: 29805522
Ref: Anti-proliferative and anti-invasive effects of garcinol from Garcinia indica on gallbladder carcinoma cells.
PMID: 30001777
Ref: Tumor suppressor LKB1 inhibits the progression of gallbladder carcinoma and predicts the prognosis of patients with this malignancy.
PMID: 30015925
Ref: Long noncoding RNA HEGBC promotes tumorigenesis and metastasis of gallbladder cancer via forming a positive feedback loop with IL-11/STAT3 signaling pathway.
PMID: 30086773
Ref: Clinical significance of interleukin-6 in diagnosis of lung, oral, esophageal, and gall bladder carcinomas.
PMID: 30249899